Exact Sciences (EXAS) Q4 Revenue Tops Consensus
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Sales and marketing: 26.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Sales and marketing: 26.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($2.79), may not compare to the analyst estimate of ($0.22). Revenue for the quarter came in at $466.3 million versus the consensus estimate of $446.22 million.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
